BDBM316483 2-{[(3R,6R)-1-{[2-methoxy-6-(2H-1,2,3- triazol-2-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]sulfanyl}pyridine-4- carbonitrile::US9617246, 17

SMILES COc1cccc(c1C(=O)N1C[C@@H](CC[C@H]1C)Sc1cc(ccn1)C#N)-n1nccn1

InChI Key InChIKey=UFKFQUPLVWLDJA-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 316483   

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM316483(2-{[(3R,6R)-1-{[2-methoxy-6-(2H-1,2,3- triazol-2-y...)
Affinity DataIC50: 51.2nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2019
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM316483(2-{[(3R,6R)-1-{[2-methoxy-6-(2H-1,2,3- triazol-2-y...)
Affinity DataIC50: 5.88E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2019
Entry Details
US Patent